Vytrus Biotech Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
39
- Stock Symbol
-
VYT
- Share Price
-
$14.53
- (As of Friday Closing)
Vytrus Biotech General Information
Description
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
Contact Information
Website
www.vytrus.comCorporate Office
- 121 Sant Gaietà
- 2nd floor Terrassa
- 08221 Barcelona
- Spain
Corporate Office
- 121 Sant Gaietà
- 2nd floor Terrassa
- 08221 Barcelona
- Spain
Vytrus Biotech Stock Performance
As of 13-Nov-2026, Vytrus Biotech’s stock price is $14.53. Its current market cap is $109M with 7.52M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $14.53 | $14.65 | $8.92 - $24.24 | $109M | 7.52M | 2.87K | $0.64 |
Vytrus Biotech Financials Summary
As of 30-Jun-2026, Vytrus Biotech has a trailing 12-month revenue of $11.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 148,597 | 68,942 | 17,679 | 15,134 |
| Revenue | 11,662 | 9,444 | 5,459 | 4,044 |
| EBITDA | 6,450 | 4,625 | 1,874 | 1,118 |
| Net Income | 4,704 | 3,267 | 1,105 | 590 |
| Total Assets | 20,059 | 17,223 | 11,583 | 10,297 |
| Total Debt | 2,279 | 2,318 | 2,577 | 3,153 |
Vytrus Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vytrus Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Vytrus Biotech Patents
Vytrus Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3096327-A1 | Abscisic acid for the treatment of skin diseases | Pending | 12-Apr-2018 | ||
| EP-3773905-A1 | Abscisic acid for the treatment of skin diseases | Pending | 12-Apr-2018 | ||
| US-20210161842-A1 | Abscisic acid for the treatment of skin diseases | Pending | 12-Apr-2018 | ||
| WO-2019197580-A1 | Abscisic acid for the treatment of skin diseases | Inactive | 12-Apr-2018 | ||
| EP-3442556-A1 | Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment | Active | 11-Apr-2016 | C07K7/06 |
Vytrus Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vytrus Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vytrus Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Vytrus Biotech FAQs
-
When was Vytrus Biotech founded?
Vytrus Biotech was founded in 2009.
-
Where is Vytrus Biotech headquartered?
Vytrus Biotech is headquartered in Barcelona, Spain.
-
What is the size of Vytrus Biotech?
Vytrus Biotech has 39 total employees.
-
What industry is Vytrus Biotech in?
Vytrus Biotech’s primary industry is Biotechnology.
-
Is Vytrus Biotech a private or public company?
Vytrus Biotech is a Public company.
-
What is Vytrus Biotech’s stock symbol?
The ticker symbol for Vytrus Biotech is VYT.
-
What is the current stock price of Vytrus Biotech?
As of 13-Nov-2026 the stock price of Vytrus Biotech is $14.53.
-
What is the current market cap of Vytrus Biotech?
The current market capitalization of Vytrus Biotech is $109M.
-
What is Vytrus Biotech’s current revenue?
The trailing twelve month revenue for Vytrus Biotech is $11.7M.
-
What is Vytrus Biotech’s annual earnings per share (EPS)?
Vytrus Biotech’s EPS for 12 months was $0.64.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
